Amylyx Pharmaceuticals, Inc. Quarterly Assets, Current in USD from Q4 2021 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Amylyx Pharmaceuticals, Inc. quarterly Assets, Current history and growth rate from Q4 2021 to Q3 2024.
Amylyx Pharmaceuticals, Inc. Assets, Current for the quarter ending September 30, 2024 was $245M, a 43.5% decline year-over-year.

Assets, Current, Quarterly (USD)

Assets, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$245M	-$189M	-43.5%	Sep 30, 2024	10-Q	2024-11-07
Q2 2024	$327M	-$101M	-23.6%	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	$411M	+$21.5M	+5.52%	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$465M	+$82.5M	+21.6%	Dec 31, 2023	10-Q	2024-11-07
Q3 2023	$434M	+$262M	+152%	Sep 30, 2023	10-Q	2023-11-09
Q2 2023	$427M	+$211M	+97.7%	Jun 30, 2023	10-Q	2023-08-10
Q1 2023	$389M	+$124M	+46.5%	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$382M	+$277M	+264%	Dec 31, 2022	10-K	2024-02-22
Q3 2022	$172M			Sep 30, 2022	10-Q	2022-11-10
Q2 2022	$216M			Jun 30, 2022	10-Q	2022-08-11
Q1 2022	$265M			Mar 31, 2022	10-Q	2022-05-12
Q4 2021	$105M			Dec 31, 2021	10-K	2023-03-13

* An asterisk sign (*) next to the value indicates that the value is likely invalid.